Henry Schein (NASDAQ:HSIC) Price Target Raised to $90.00

Henry Schein (NASDAQ:HSIC) had its price objective lifted by investment analysts at Evercore ISI from $83.00 to $90.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Evercore ISI’s price target indicates a potential upside of 25.68% from the stock’s current price.

HSIC has been the subject of several other research reports. Leerink Partners set a $75.00 target price on shares of Henry Schein in a report on Monday, July 14th. UBS Group reduced their price objective on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Stifel Nicolaus reissued a “hold” rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. JPMorgan Chase & Co. dropped their target price on Henry Schein from $80.00 to $76.00 and set an “overweight” rating for the company in a research report on Thursday, August 7th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Henry Schein in a report on Friday, October 31st. Five equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $77.25.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $71.61 on Wednesday. The company has a market cap of $8.68 billion, a P/E ratio of 23.10, a P/E/G ratio of 2.06 and a beta of 0.81. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The firm’s fifty day moving average is $66.17 and its two-hundred day moving average is $68.61.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.34 billion during the quarter, compared to analyst estimates of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. As a group, analysts anticipate that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Teacher Retirement System of Texas bought a new position in shares of Henry Schein during the 1st quarter worth $3,293,000. OneDigital Investment Advisors LLC raised its holdings in shares of Henry Schein by 22.5% in the first quarter. OneDigital Investment Advisors LLC now owns 4,917 shares of the company’s stock valued at $337,000 after acquiring an additional 903 shares in the last quarter. IFM Investors Pty Ltd lifted its stake in Henry Schein by 6.6% in the first quarter. IFM Investors Pty Ltd now owns 23,831 shares of the company’s stock worth $1,737,000 after acquiring an additional 1,482 shares during the period. DekaBank Deutsche Girozentrale grew its holdings in Henry Schein by 0.8% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 961,161 shares of the company’s stock worth $65,205,000 after acquiring an additional 7,369 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its position in Henry Schein by 5.8% during the 1st quarter. Nisa Investment Advisors LLC now owns 31,866 shares of the company’s stock valued at $2,183,000 after purchasing an additional 1,751 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.